Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Oct 16 2020

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-16-2020-5

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 16, 2020, titled "Alembic Pharmaceuticals announces USFDA Approval for Amantadine Hydrochloride Tablets, 100 mg.".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases